Im always suspicious when the quarterly comes out after market close. There is a lot of padding which sadly doesn't disguise the fact that this is a particularly poor result for a company that should be ramping into its growth phase by now.
While I applaud the fact that they are trying to restrain cash burn it is alarming how rapid their spend is.
I don't know where fair value is going to be here but this is going to get uglier first.
- Forums
- ASX - By Stock
- 1PG
- Ann: 1PG Quarterly Commentary and Appendix 4C - 30 April 2016-1PG.AX
Ann: 1PG Quarterly Commentary and Appendix 4C - 30 April 2016-1PG.AX, page-22
-
- There are more pages in this discussion • 59 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 1PG (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online